Using High-Throughput Surface Plasmon Resonance for In-Depth Antibody Characterization
Antibody-based therapeutics are central to drug discovery but present significant analytical challenges due to their complex and heterogeneous nature. Surface Plasmon Resonance (SPR) is ideal for analyzing antibodies, measuring binding kinetics, and performing epitope binning and mapping, which is essential for developing high-precision ELISA or multiplex assays. Aviva Systems Biology leverages decades of expertise in antibodies and ELISA, combined with the innovative Carterra LSA, to offer high-throughput antibody characterization services.
Webinar Highlights:
Interested in antibody characterization in your own work?
About Aviva Systems Biology
Founded in 2002, Aviva Systems Biology supports scientists in their basic research, preclinical, drug development, and diagnostics workflows. With an extensive portfolio of nearly 500,000 products for antibodies, proteins, and immunoassays and over 20 years of expertise in antibody and protein production, scientists can find the unique reagents and support they need for success in their work.
Meet the Experts:
Kevin Harvey, PhD President of Aviva Systems Biology
